Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Clinical trial NCT02570490 · COMPLETED
Trial details
- NCT number
- NCT02570490
- Sponsor
- Arrevus Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.